134 related articles for article (PubMed ID: 1856233)
21. Idiotypic cross-reactivity of low-affinity anti-fluorescyl monoclonal antibodies.
Reinitz DM; Voss EW
Mol Immunol; 1984 Sep; 21(9):775-84. PubMed ID: 6434941
[TBL] [Abstract][Full Text] [Related]
22. Polyclonal antibodies specific for liganded active site (metatype) of a high affinity anti-hapten monoclonal antibody.
Voss EW; Miklasz SD; Petrossian A; Dombrink-Kurtzman MA
Mol Immunol; 1988 Aug; 25(8):751-9. PubMed ID: 3185570
[TBL] [Abstract][Full Text] [Related]
23. High-affinity rat anti-fluorescein monoclonal antibody with unique fine specificity properties including differential recognition of dynamic ligand analogues.
Miklasz SD; Gulliver GA; Voss EW
J Mol Recognit; 1995; 8(4):258-69. PubMed ID: 8588943
[TBL] [Abstract][Full Text] [Related]
24. Substantial energetic improvement with minimal structural perturbation in a high affinity mutant antibody.
Midelfort KS; Hernandez HH; Lippow SM; Tidor B; Drennan CL; Wittrup KD
J Mol Biol; 2004 Oct; 343(3):685-701. PubMed ID: 15465055
[TBL] [Abstract][Full Text] [Related]
25. Similarity between fluorescein-specific T-cell receptor and antibody in chemical details of antigen recognition.
Ganju RK; Smiley ST; Bajorath J; Novotny J; Reinherz EL
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11552-6. PubMed ID: 1454847
[TBL] [Abstract][Full Text] [Related]
26. Molecular modeling and site-directed mutagenesis of an anti-phosphotyrosine antibody predicts the combining site and allows the detection of higher affinity interactions.
Ruff-Jamison S; Glenney JR
Protein Eng; 1993 Aug; 6(6):661-8. PubMed ID: 7694275
[TBL] [Abstract][Full Text] [Related]
27. Critical interactions in binding antibody NC41 to influenza N9 neuraminidase: amino acid contacts on the antibody heavy chain.
Pruett PS; Air GM
Biochemistry; 1998 Jul; 37(30):10660-70. PubMed ID: 9692956
[TBL] [Abstract][Full Text] [Related]
28. Comparative circular dichroism studies of an anti-fluorescein monoclonal antibody (Mab 4-4-20) and its derivatives.
Tetin SYu ; Mantulin WW; Denzin LK; Weidner KM; Voss EW
Biochemistry; 1992 Dec; 31(48):12029-34. PubMed ID: 1457402
[TBL] [Abstract][Full Text] [Related]
29. An analysis of idiotype expression in a high-affinity, somatically mutated variant of a germline-encoded anti-p-azobenzenearsonate antibody.
Nisonoff A; Oliveira TM; Sharon J
Int Immunol; 1993 Jan; 5(1):1-9. PubMed ID: 8443119
[TBL] [Abstract][Full Text] [Related]
30. Immunological characterization of xenogenic anti-metatype antibodies.
Weidner KM; Voss EW
J Biol Chem; 1991 Feb; 266(4):2513-9. PubMed ID: 1899241
[TBL] [Abstract][Full Text] [Related]
31. Inter-relationship between immunoglobulin idiotype and metatype.
Voss EW; Dombrink-Kurtzman MA; Ballard DW
Mol Immunol; 1989 Oct; 26(10):971-7. PubMed ID: 2480517
[TBL] [Abstract][Full Text] [Related]
32. Identification of residues in the monoclonal antitumor antibody L6 important for binding to its tumor antigen.
Stenzel-Johnson PR; Yelton D; Bajorath J
Biochemistry; 1994 Dec; 33(48):14400-6. PubMed ID: 7526900
[TBL] [Abstract][Full Text] [Related]
33. Three-dimensional structure of a fluorescein-Fab complex crystallized in 2-methyl-2,4-pentanediol.
Herron JN; He XM; Mason ML; Voss EW; Edmundson AB
Proteins; 1989; 5(4):271-80. PubMed ID: 2508085
[TBL] [Abstract][Full Text] [Related]
34. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).
Li Y; Li H; Smith-Gill SJ; Mariuzza RA
Biochemistry; 2000 May; 39(21):6296-309. PubMed ID: 10828942
[TBL] [Abstract][Full Text] [Related]
35. DNA hydrolysis by monoclonal anti-ssDNA autoantibody BV 04-01: origins of catalytic activity.
Gololobov GV; Rumbley CA; Rumbley JN; Schourov DV; Makarevich OI; Gabibov AG; Voss EW; Rodkey LS
Mol Immunol; 1997 Oct; 34(15):1083-93. PubMed ID: 9519766
[TBL] [Abstract][Full Text] [Related]
36. A V kappa-J kappa junctional change in an antidigoxin recombinant antibody destroys digoxin-binding activity.
Hudson NW; Bruccoleri RE; Steinrauf LK; Hamilton JA; Mudgett-Hunter M; Margolies MN
J Immunol; 1990 Oct; 145(8):2718-24. PubMed ID: 2120338
[TBL] [Abstract][Full Text] [Related]
37. Three-dimensional structures of idiotypically related Fabs with intermediate and high affinity for fluorescein.
Terzyan S; Ramsland PA; Voss EW; Herron JN; Edmundson AB
J Mol Biol; 2004 Jun; 339(5):1141-51. PubMed ID: 15178254
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of ligand binding by monoclonal anti-fluorescyl antibodies.
Kranz DM; Herron JN; Voss EW
J Biol Chem; 1982 Jun; 257(12):6987-95. PubMed ID: 6806261
[TBL] [Abstract][Full Text] [Related]
39. Quenching of fluorescein-conjugated lipids by antibodies. Quantitative recognition and binding of lipid-bound haptens in biomembrane models, formation of two-dimensional protein domains and molecular dynamics simulations.
Ahlers M; Grainger DW; Herron JN; Lim K; Ringsdorf H; Salesse C
Biophys J; 1992 Sep; 63(3):823-38. PubMed ID: 1420916
[TBL] [Abstract][Full Text] [Related]
40. Antibody framework residues affecting the conformation of the hypervariable loops.
Foote J; Winter G
J Mol Biol; 1992 Mar; 224(2):487-99. PubMed ID: 1560463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
